Treatment of Long-COVID Neuropsychiatric Sequelae Using Tricyclic Antidepressants: A Case Series

J Clin Psychopharmacol. 2023 Sep-Oct;43(5):458-460. doi: 10.1097/JCP.0000000000001725. Epub 2023 Jun 22.

Authors

Michael S La Sala¹, Samuel Reinfeld, Eduardo Constantino

Affiliation

¹ From the Department of Psychiatry and Behavioral Health, Stony Brook University Renaissance School of Medicine, Stony Brook, NY Michael.Lasala@stonybrookmedicine.edu .

PMID: 37683237
DOI: 10.1097/JCP.0000000000001725

No abstract available

MeSH terms

Antidepressive Agents, Tricyclic* / adverse effects
COVID-19*
Humans
Post-Acute COVID-19 Syndrome

Substances

Antidepressive Agents, Tricyclic